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Background: Secondhand smoke (SHS) and ambient air pollution (AAP) exposures have been associated with
increased prevalence and severity of asthma and DNA modifications of immune cells. In the current study, we
examined the association between SHS and AAP with DNA methylation and expression of interferon-gamma (IFN-γ)
and forkhead box protein 3 (Foxp3) in T cell populations.
Methods: Subjects 7–18 years old were recruited from Fresno (high AAP; n = 62) and Stanford, CA (low AAP; n = 40)
and divided into SHS-exposed (Fresno: n = 31, Stanford: n = 6) and non-SHS-exposed (nSHS; Fresno: n = 31, Stanford:
n = 34) groups. T cells purified from peripheral blood were assessed for levels of DNA methylation and expression of
IFN-γ (in effector T cells) or Foxp3 (in regulatory T cells).
Results: Analysis showed a significant increase in mean % CpG methylation of IFN-γ and Foxp3 associated with SHS
exposure (IFN-γ: FSHS 62.10%, FnSHS 41.29%, p< 0.05; SSHS 46.67%, SnSHS 24.85%, p< 0.05; Foxp3: FSHS 74.60%,
FnSHS 54.44%, p< 0.05; SSHS 62.40%, SnSHS 18.41%, p< 0.05) and a significant decrease in mean transcription levels
of both genes (IFN-γ: FSHS 0.75, FnSHS 1.52, p< 0.05; SHS 2.25, nSHS 3.53, p< 0.05; Foxp3: FSHS 0.75, FnSHS 3.29,
p< 0.05; SSHS 4.8, SnSHS 7.2, p< 0.05). AAP was also associated with hypermethylation (IFN-γ: FSHS vs. SSHS,
p< 0.05; FnSHS vs. SnSHS, p< 0.05; Foxp3: FSHS vs. SSHS, p< 0.05; FnSHS vs. SnSHS, p< 0.05) and decreased
transcription of both genes (IFN-γ: FSHS vs. SSHS, p< 0.05; FnSHS vs. SnSHS, p< 0.05; Foxp3: FSHS vs. SSHS, p< 0.05;
FnSHS vs. SnSHS, p< 0.05). Average methylation between AAP- and SHS-only exposures was not significantly
different (IFN-γ: p= 0.15; Foxp3: p= 0.27), nor was Foxp3 expression (p= 0.08); IFN-γ expression was significantly
decreased in AAP-only subjects (p< 0.05).
Conclusions: Exposures to SHS and AAP are associated with significant hypermethylation and decreased
expression of IFN-γ in Teffs and Foxp3 in Tregs. Relative contributions of each exposure to DNA modification and
asthma pathogenesis warrant further investigation.
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Exposure to secondhand smoke (SHS) is associated with
a number of adverse health effects, including cancer, car-
diovascular disease, and increased frequency and severity
of respiratory disease [1]. Per the US Surgeon General’s
2006 report, any exposure to SHS results in increased
health risks [1]. The World Health Organization (WHO)
estimates that 22% of women and 35% of men in devel-
oped countries smoke cigarettes [2]; in the US alone, it
has been estimated that over 126 million nonsmokers
are exposed to SHS [3]. Most SHS exposure occurs in
the home, thus making children the most vulnerable
population: the WHO estimates that 40% of children
worldwide are exposed to SHS at home [2,3].
Of particular interest is SHS’s role in the development
and exacerbation of asthma and allergic disease. Asthma
is the most common chronic disease in children [4], and
numerous studies have associated both pre- and postna-
tal SHS exposure with increased life-long risk of asthma,
with evidence of this association passing between genera-
tions [1,3,5-7]. In fact, SHS exposure has been estimated
to cause asthma symptoms in 200,000 to 1 million chil-
dren, contributing to anywhere from 8,000 to 26,000 new
cases each year [3]. Many asthmatic children are also
atopic (that is, display allergic sensitization to aeroaller-
gens). Atopy and allergic rhinitis also have been asso-
ciated with parental smoking and SHS exposure [5],
though the relationship between SHS and allergic rhinitis
is unclear [2].
SHS is not the only environmental exposure implicated
in these diseases; ambient air pollution (AAP) is also
known to contribute. AAP includes such compounds as
polycyclic aromatic hydrocarbons (PAH), particulate
matter with a diameter ≤ 2.5 μm (PM2.5), particulate mat-
ter with a diameter ≤ 10 μm (PM10), elemental carbon,
and ozone, and is also known to be associated with
increased prevalence and severity of various diseases and
adverse health effects, including asthma and allergies
[8,9]. Again, children are particularly vulnerable.
Because smoking (and consequently SHS exposure)
and AAP are so widespread, understanding the mechan-
isms by which SHS in combination with AAP impacts
human health is crucial, especially with regard to children.
A recent study asked which environmental exposure
(acute SHS exposure vs. AAP exposure, using cotinine
to measure SHS exposure and PM2.5 to measure AAP
exposure) played more of a role in children’s respiratory
health; their clinical data suggested that SHS modulates
the acute impact of PM2.5 exposure on asthma in chil-
dren, implying that acute SHS exposure has a greater
effect on respiratory health than does acute AAP expos-
ure [10]. Our group has published data on ambient air
pollution exposure (specifically focusing on PAH) and
its effects on asthma and regulatory T cell function [4].Exposure to both mainstream cigarette smoking and SHS
has been shown to have sustained impacts on health
[3,5,11-13]. Most strikingly, these effects have been
shown to pass between generations [6], suggesting that
one way SHS may impact human health is via epigenetic
alteration. In utero smoke exposure from maternal
smoking has been associated with changes in both global
DNA methylation and methylation of specific genes
[11,12,14,15]. Moreover, various components of AAP that
are shared with SHS (for example, PAH) have been found
to impact DNA methylation [3,11,16,17]. Therefore, we
chose to study the mechanisms underlying the combined
effects of SHS and AAP on specific immune cells that are
associated with health outcomes such as asthma.
We chose to focus our mechanistic studies on the epi-
genetic regulation of interferon-gamma (IFN-γ), a Th1
cytokine that is a known negative regulator of allergic
responses [18,19], and forkhead box transcription factor
3 (Foxp3), which is essential to the development and
function of T regulatory cells (Tregs) [4]. Transcription
and expression of both these genes are influenced by
methylation of cytosine nucleotide neighboring guanine
(CpG) sites. IFN-γ expression is inversely related to the
degree of methylation of specific CpG sites within the
gene [20-22]. The CpG site in the promoter of IFN-γ is
hypomethylated in Th1 cells and hypermethylated in
Th2 cells (both subsets of T effector cells, or Teffs), the
latter of which are associated with pro-allergic and
-inflammatory responses [23,24]. Foxp3 is also negatively
regulated by CpG methylation of its transcriptional regu-
latory regions [25], requiring complete demethylation of
its CpG sites for stable expression [26]. In Tregs, which
require stable Foxp3 expression to function normally [4],
the gene’s promoter is completely demethylated [27].
Studies have shown that CpG methylation of regulatory
elements of both IFN-γ and Foxp3 is affected by environ-
mental exposures. Liu et al. [28] found that a combin-
ation of diesel exhaust particle and allergen exposure in
an allergic mouse model led to hypermethylation of three
CpG sites in the IFN-γ promoter, as well as increased IgE
production. Kwon et al. [23] showed that stimulation of
CD4+ cells from adult asthmatic patients sensitized to
dust mite with phytohemagglutinin (PHA) altered the
methylation of various CpG sites surrounding the pro-
moter of the IFN-γ gene, though no consistent pattern
emerged across the sites. Nadeau et al. [4] found that
increased exposure to AAP (specifically, PAH) was asso-
ciated with hypermethylation of Foxp3 as well as impaired
Treg function and increased rates and severity of asthma.
We examined the association between SHS in combin-
ation with AAP (specifically, PM2.5, PM10, PAH, and
ozone, all of which have been shown to impact respira-
tory symptoms as well as T cell ratios and levels of cyto-
kines such as IFN-γ, IL-4, and IL-17 [29-33]), and the
Table 1 Comparison of ambient air pollutant concentrations between Fresno and Palo Alto, CA, based on California Air
Resources Board (CARB) compliance monitoring for 2011
Pollutant Location of compliance monitor
Redwood City* First Street, Fresno
PAHs, annual average (ng/m3) 84 1,068
PM2.5, annual average (μg/m
3) Insufficient data 15.9
PM2.5, 24-h maximum (μg/m
3) 24.0 78.5
PM10, annual average (μg/m
3) Insufficient data 29.6
PM10, 24-h high (μg/m
3) Insufficient data 99.5
O3, highest 8-h average (ppb) 62 97
O3, number of days > state 1-h standard 0 14
O3, number of days > state 8-h standard 0 54
PM2.5, particulate matter with aerodynamic diameter≤ 2.5 μm; PM10, particulate matter with aerodynamic diameter ≤10 μm; PAH, polycyclic aromatic
hydrocarbon; O3, ozone.
*Redwood City is the nearest compliance monitor, within 4.7 km of the Palo Alto residences of the Stanford cohort. All Fresno subjects live within a circle with the
First Street monitor as its center and a radius of 20 km.
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Tregs, of children under 18 years. AAP-exposed subjects
were recruited from Fresno, California, which has very
high rates of ambient air pollution and asthma [4]. Con-
trol subjects (subjects not exposed to high levels of AAP)
were recruited from Palo Alto, California (referred to as
the Stanford cohort in this paper), which has relatively
low rates of ambient air pollution (Table 1).
Drawing on evidence from previous studies examining
the impact of environmental exposures on these genes,
we hypothesized that exposure to SHS and AAP in chil-
dren might increase methylation of regulatory elements
in IFN-γ and Foxp3 in Teffs and Tregs, respectively, and
that this would lead to decreased expression of these
genes in their respective cell types, with this effect more
prominent in subjects exposed to SHS in combination
with AAP vs. in subjects exposed to one or the other.
Results
General subject characteristics
Demographics of subjects are summarized in Table 2.
Subjects from the Fresno cohort were divided into twoTable 2 Demographics of subjects
Fresno SHS*
(n = 31)
Age, years 14.13 ± 0.36
(range 11 to 18)
Gender, male/female 15/16
Number with allergic rhinitis 9 (29.0%)
IgE levels, kU/L 76 ± 15
Urine cotinine, ng/mL 12.36 ± 6.86
(n = 16)
Number of subjects with positive
urine cotinine levels (> 7 ng/mL)
5 (31.25%)
(n = 16)
*Two subjects each in both the Fresno and Stanford SHS groups were themselves s
nSHS, not exposed to secondhand smoke; kU/L, kilounits per liter; ng/mL, nanogramgroups based on SHS exposure: subjects with secondhand
smoke exposure (FSHS) (n = 31) and subjects without
secondhand smoke exposure (FnSHS) (n = 31). Subjects
from the Stanford cohort (n = 40) were also divided into
two control groups: thirty-four subjects without SHS
exposure (SnSHS), and six with SHS exposure (SSHS).
Mean ages within and between the Fresno and Stanford
subject groups differed significantly (summarized in
Table 2; P < 0.05). Male-to-female ratios within and be-
tween groups did not differ significantly (Table 2). IgE
levels were significantly elevated in FSHS subjects com-
pared to FnSHS subjects and SnSHS subjects, but not
compared to SSHS subjects (FSHS mean ± SEM 76±
15 kU/L, FnSHS mean: 13 ± 7, P < 0.05; SnSHS mean:
11 ± 5 kU/L, P < 0.05; SSHS mean: 23 ± 9 kU/L, P= 0.14).
IgE levels did not differ significantly between FnSHS sub-
jects and SnSHS subjects, nor did they differ significantly
between SSHS and SnSHS subjects. Allergic rhinitis
prevalence did not differ significantly between any of the
groups.
As proof of concept that our screening process to dis-
tinguish between subjects who were exposed to SHS andFresno nSHS Stanford SHS* Stanford nSHS
(n =31) (n = 6) (n = 34)
15.23 ± 0.28
(range 12 to 18)
16.17 ± 1.45
(range 9 to 18)
11.85 ± 3.13
(range 7 to 18)
20/11 2/4 17/17
9 (29.0%) 2 (33%) 6 (17%)
13 ± 7 23 ± 9 11 ± 5
0 ± 0 n/a n/a
(n = 6)
0 (0%) n/a n/a
(n = 6)
mokers in addition to being exposed to SHS. SHS, secondhand smoke;
s per milliliter. Means are reported ± standard error of the mean (SEM).
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Fresno groups were chosen randomly for analysis of
urine cotinine content via ELISA (FSHS n= 16, FnSHS
n= 6). Urine cotinine levels were significantly greater in
SHS-exposed subjects vs. non-SHS-exposed subjects, but
the percentage of FSHS subjects showing urine cotinine
levels above the threshold value of 7 ng/mL was not sig-
nificant (FSHS mean cotinine ± SEM: 12.36 ng/mL ±6.86,
FnSHS mean: 0 ± 0, P < 0.05; FSHS above 7 ng/mL:
31.25%, FnSHS above 7 ng/mL: 0%, P= 0.27). Urinary
cotinine was not measured for the Stanford subjects.
IFN-γ in Teffs
Methylation of 6 CpG sites in the promoter region of the
IFN-γ locus was analyzed via pyrosequencing (Figure 1).
Sites were considered methylated only if they were
methylated in 70% or more of all pyrosequencing reac-
tions. Percent methylation for each individual was calcu-
lated by dividing the number of methylated CpG sites by
the total number of CpG sites examined. We compared
the average percent methylation of IFN-γ between Teffs
of FSHS, FnSHS, SSHS, and SnSHS subjects. Two-way
analysis of variance (ANOVA) found a significant source
of variation associated with SHS exposure (35.12% of
total variation, P < 0.05) and with AAP exposure (19.63%
of total variation, P < 0.05), with no significant interaction
effect (0.02% of total variation, P= 0.84). T-tests showed
the average methylation of IFN-γ was significantly
greater in the Teffs from FSHS subjects than in the Teffs
from FnSHS subjects (Figure 2A; FSHS mean± SEM:
62.10%± 2.12%, FnSHS mean: 41.29%± 1.94%, P < 0.05;
Hedge’s g: 1.82, 95% CI [1.60, 2.10]), as well as in the
Teffs from SSHS subjects vs. SnSHS subjects (Figure 2A;
SSHS mean ± SEM: 46.67%± 2.47%, SnSHS mean:
24.85%± 0.99%, P < 0.05; Hedge’s g: 4.01, 95% CI [3.67,
4.5]). IFN-γ average methylation in Teffs was also signifi-
cantly larger in FSHS vs. SSHS subjects (Figure 2A;
P < 0.05; Hedge’s g: 1.35, 95% CI [1.17, 1.60]), but did not
differ significantly between FnSHS and SSHS subjects
(Figure 2A; P= 0.16). The effect size of AAP alone
(FnSHS vs. SnSHS) was calculated to be 1.90 (95% CI
[1.62, 2.23]), and the combined effect size of SHS and
AAP exposure on IFN-γ methylation (FSHS vs. SnSHS)
was calculated to be 4.01 (95% CI [3.67, 4.5]).
Transcription of IFN-γ in Teffs from all populations
was compared to transcription levels of β-glucuronidaseFigure 1 Diagrammatic representation of the IFN-γ promoter region [
guanine (CpG) dinucleotide sequences that can be potentially methylated.
the transcription start, which is indicated as +1 bp (base pair).(GUS), a housekeeping gene, with expression reported as
multiples of GUS expression. Two-way ANOVA found
significant sources of variation associated with SHS
exposure (19.26% of total variation, P < 0.05) and AAP
exposure (56.53% of total variation, P < 0.05), though
because a significant interaction effect was also seen
(1.21% of total variation, P < 0.05), these results are ques-
tionable. Expression of IFN-γ was found to be decreased
in the Teffs of FSHS subjects compared to FnSHS sub-
jects (Figure 2B; FSHS mean± SEM: 0.75 ± 0.05, FnSHS
mean: 1.52 ± 0.11, P < 0.05; Hedge’s g: –1.67, 95% CI
[−3.30, –0.07]), as well as in the Teffs of SSHS vs. SnSHS
subjects (Figure 2B; SSHS mean ± SEM: 2.25 ± 0.17,
SnSHS mean: 3.53 ± 0.07, P < 0.05; Hedge’s g: –2.96, 95%
CI [−4.26, –1.79]). Average IFN-γ expression in Teffs was
significantly lower in FSHS subjects than in SSHS sub-
jects (P < 0.05; Hedge’s g: –5.17, 95% CI [−7.8, –2.75]).
Expression was also significantly lower in FnSHS subjects
vs. SSHS subjects (P < 0.05) as well as vs. SnSHS subjects
(P < 0.05; Hedge’s g: –3.89, 95% CI [−5.50, –2.37]). The
combined effect size of AAP+ SHS (FSHS vs. SnSHS)
was calculated to be −7.74 (95% CI [−10.80, –4.87]).
Linear regression analysis was performed to examine
the association between methylation and transcription
levels of IFN-γ in Teffs. Within the FSHS, FnSHS, and
SSHS groups, no significant relationship between methy-
lation and transcription levels was evident (data not
shown); a significant positive association existed within
the SnSHS group (Spearman r= 0.38, P < 0.05, R2= 0.16,
data not shown). Within the Fresno group, there was a
significant negative association between methylation and
expression levels of IFN-γ in Teffs (Spearman r=−0.67,
P < 0.05; R2= 0.27; data not shown); no significant correl-
ation was seen in the Stanford group (Spearman r=−0.08,
P=n.s.; R2=0.20; data not shown). A significant negative
association between methylation and transcription levels
was seen in both the SHS and nSHS groups (including
members from both Fresno and Stanford, Figure 2C and
2D; SHS Spearman r=−0.36, P < 0.05, R2= 0.20; nSHS
Spearman r=−0.58, P < 0.05, R2= 0.38); the same held
true when all subjects were analyzed (Figure 2E; Spear-
man r=−0.75, P < 0.05; R2= 0.56).
Linear regression analyses comparing age and methy-
lation levels and age and transcript levels were also per-
formed to determine if age was a confounding factor,
but no significant associations between age and percentJ00219: GenBank]. Vertical arrows indicate cytosine neighboring






























































































































Figure 2 (See legend on next page.)
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(data not shown). Additionally, the average percent
methylation and average transcript levels of IFN-γ for
each gender were compared, and no significant differ-
ence in methylation was found between males and
females within either group.Foxp3 in Tregs
Average percent methylation of 13 CpG sites in the pro-
moter and intron region of Foxp3 (Figure 3) in Tregs
was compared between all four groups. As with analysis
of IFN-γ, sites were considered positively methylated if
they were found to be methylated in 70% or more of
(See figure on previous page.)
Figure 2 Methylation and expression of IFN-γ in T effector cells (Teffs) of all subjects. A. Comparison of overall methylation of examined
cytosine nucleotide neighboring guanine (CpG) sites in IFN-γ in Teffs between Fresno subjects exposed to secondhand smoke (SHS) (FSHS)
(n = 31), Fresno subjects not exposed to SHS (FnSHS) (n = 31), Stanford subjects exposed to SHS (SSHS) (n = 6), and Stanford subjects who were
not exposed (SnSHS) (n = 34) groups. Methylation is reported as percent methylated CpG sites out of 6 total examined CpG sites (Figure 1); the
cutoff for positive methylation at each site was set at 70% of all sequencing reactions. Error bars represent standard error of the mean (SEM).
B. Comparison of expression of IFN-γ in Teffs between FSHS, FnSHS, SSHS, and SnSHS groups. Expression is reported as fold expression relative to
the expression of the housekeeping gene beta-glucuronidase (GUS). Error bars represent SEM. C. Linear regression analysis of IFN-γ expression in
Teffs vs. % methylation of IFN-γ from all SHS subjects. D. Linear regression analysis of IFN-γ expression in Teffs vs. % methylation of IFN-γ from all
nSHS subjects. E. Linear regression analysis of IFN-γ expression in Teffs vs. % methylation of IFN-γ from all subjects. FSHS, Fresno group exposed to
secondhand smoke; FnSHS, Fresno group not exposed to secondhand smoke; SSHS, Stanford group exposed to secondhand smoke; SnSHS,
Stanford group not exposed to secondhand smoke; n.s., not significant. *P< 0.05.
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each individual by dividing the number of methylated
CpG sites by the total number of CpG sites examined.
Two-way ANOVA found significant effects on variation
associated with SHS (39.08% of total variation, P < 0.05)
and AAP (22.74% of total variation, P < 0.05), but a sig-
nificant interaction effect was also seen (5.28% of total
variation, P < 0.05). Average methylation of Foxp3 regula-
tory sites in the Tregs of FSHS subjects was significantly
greater than in the Tregs of FnSHS subjects (Figure 4A;
FSHS mean±SEM: 74.60%±2.24%, FnSHS mean: 54.44%±
2.83%, P < 0.05; Hedge’s g: 1.40, 95% CI [1.22, 1.62]); the
same held true for Foxp3 in the Tregs of SSHS subjects
vs. SnSHS subjects (Figure 4A; SSHS mean ± SEM:
62.0%± 1.80%, SnSHS mean: 18.41%± 0.09%, P < 0.05;
Hedge’s g: 8.26, 95% CI [7.71, 9.15]). Methylation of
Foxp3 in Tregs was significantly increased in FSHS sub-
jects compared to SSHS subjects (Figure 4A; P < 0.05;
Hedge’s g: 1.05, 95% CI [0.89, 1.26]), as was methylation
of Foxp3 in the Tregs of FnSHS subjects vs. SnSHS sub-
jects (Figure 4A; P < 0.05; Hedge’s g: 3.09, 95% CI [2.76,
3.50]). There was no significant difference between aver-
age methylation of Foxp3 in Tregs of FnSHS and SSHS
subjects (Figure 4A; P= 0.27). The effect size of SHS in
combination with AAP (FSHS vs. SnSHS) was calculated
to be 5.89 (95% CI [5.45, 6.47]).
Transcription of Foxp3 in Tregs from all populations
was compared with transcription levels of GUS to obtain
fold expression levels. Average fold expression was com-
pared between groups. Two-way ANOVA found signifi-
cant effects associated with SHS (20.42% of total
variation, P < 0.05) and AAP (52.77% of total variation,
P<0.05), with no significant interaction between exposureFigure 3 Diagrammatic representation of Foxp3 promoter and intron
neighboring guanine (CpG) dinucleotide sequences that can be potentially
relation to the transcription start, which is indicated as +1 bp (base pair).effects (0.02% of total variation, P= 0.80). Expression of
Foxp3 was found to be significantly decreased in the
Tregs of FSHS subjects compared to FnSHS subjects
(Figure 4B; FSHS mean ± SEM: 0.75 ± 0.05, FnSHS mean:
3.30 ± 0.35, P < 0.05; Hedge’s g: –1.81, 95% CI [−3.26,
–0.40]); the same was true of Foxp3 expression in Tregs
of SSHS subjects vs. SnSHS subjects (Figure 4B; SSHS
mean ± SEM: 4.8 ± 0.09, SnSHS mean: 7.2 ± 0.08, P < 0.05;
Hedge’s g: –5.48, 95% CI [−6.88, –4.3]). Foxp3 expression
in Tregs was also significantly decreased in FSHS sub-
jects vs. SSHS subjects (Figure 4B; P < 0.05, Hedge’s g:
–15.00, 95% CI [−20.10, –10.60]) and in FnSHS subjects
vs. SnSHS subjects (Figure 4B; P < 0.05, Hedge’s g: –2.78,
95% CI [−3.72, –1.91]). No significant difference in Foxp3
expression was seen between Tregs of FnSHS and SSHS
subjects (Figure 4B; P= 0.08). Effect size of SHS in com-
bination with AAP (FSHS vs. SnSHS) was calculated to
be −16.9 (95% CI [−22.00, −12.70]).
Linear regression analysis examining methylation of
Foxp3 vs. expression levels in Tregs found a significant
negative association in FnSHS subjects (Spearman
r=−0.63, P < 0.05; R2 = 0.34; data not shown) but none
in FSHS subjects (data not shown). Within the Stanford
groups, a significant positive association between methy-
lation and expression levels was seen in the SnSHS
group (Spearman r= 0.48, P < 0.05, R2= 0.11; data not
shown) and no association was seen in the SSHS group
(data not shown). A significant negative association be-
tween methylation and expression of Foxp3 in Tregs was
seen when data from all Fresno subjects was analyzed
(Spearman r=−0.67, P < 0.05; R2= 0.46; data not shown);
no association was seen when all Stanford subjects’ data
were analyzed (data not shown). Both the SHS and nSHSic regions [NM_014009: NCBI]. Vertical arrows indicate cytosine
methylated. The position of each CpG dinucleotide site is illustrated in

























































































































Figure 4 (See legend on next page.)
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Figure 4 Methylation and expression of Foxp3 in T regulatory cells (Tregs) of all subjects. A. Comparison of overall methylation of
examined cytosine nucleotide neighboring guanine (CpG) sites in Foxp3 in Tregs between Fresno subjects exposed to secondhand smoke (SHS)
(FSHS) (n = 31), Fresno subjects not exposed to SHS (FnSHS) (n = 31), Stanford subjects exposed to SHS (SSHS) (n = 6), and Stanford subjects who
were not exposed (SnSHS) (n = 34) groups. Methylation is reported as percent methylated CpG sites out of 13 total examined CpG sites; the
cutoff for positive methylation at each site was set at 70% of all sequencing reactions. Error bars represent standard error of the mean (SEM). B.
Comparison of expression of Foxp3 in Tregs between FSHS, FnSHS, SSHS, and SnSHS groups. Expression is reported as fold expression relative to
the expression of the housekeeping gene beta-glucuronidase (GUS). Error bars represent SEM. C. Linear regression analysis of Foxp3 expression in
Tregs vs. % methylation of Foxp3 from all SHS subjects. D. Linear regression analysis of Foxp3 expression in Tregs vs. % methylation of Foxp3 in all
nSHS subjects. E. Linear regression analysis of Foxp3 expression in Tregs from all subjects vs. % methylation of Foxp3. *P< 0.05; n.s., not significant.
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and Stanford cohorts) showed a significant negative asso-
ciation between Foxp3 methylation and expression in
Tregs (Figure 4C and 4D, SHS: Spearman r=−0.54,
P < 0.05, R2= 0.17; nSHS: Spearman r=−0.71, P < 0.05,
R2= 0.72). When methylation and transcription levels of
Foxp3 were examined in all subjects, there was a signifi-
cant negative association (Figure 4E; Spearman r=−0.84,
P < 0.05, R2 = 0.77).
As with IFN-γ, linear regression analyses comparing
age and methylation levels and age and transcript levels
were also performed, but no significant associations be-
tween age and percent methylation or expression level
of Foxp3 were seen (data not shown). Additionally, to
determine if gender might be a confounding factor, the
average percent methylation and average transcript
levels of Foxp3 for each gender were compared, and no
significant difference in methylation was found between
males and females within either group (data not shown).
A summary of these results can be found in Table 3.
Discussion
Our study examined whether exposure to SHS both
alone and in combination with AAP was associated with
increased methylation and decreased expression of IFN-γ
in Teffs and of Foxp3 in Tregs. Our assessment of SHS
exposure, based on parent questionnaires, was dichot-
omous: subjects were determined to have either been
exposed to SHS or not. The validity of questionnaires
asking about parental smoking and smoking in the home
to determine pediatric exposure to SHS has been demon-
strated previously, with questionnaire-determined SHS
exposure confirmed by cotinine analysis [1,34,35]. ToTable 3 Methylation and expression of IFN-γ in T effectors an
Parameter Fresno SH
(n = 31)
IFN-γ methylation in Teffs (out of 6 CpG sites) 62.10%± 2.
IFN-γ expression in Teffs (fold expression vs. GUS) 0.75 ± 0.
Foxp3 methylation in Tregs (out of 13 CpG sites) 74.60%± 2.
Foxp3 transcription in Tregs (fold expression vs. GUS) 0.75 ± 0.
IFN-γ, interferon-gamma; Foxp3, forkhead box transcription factor 3; SHS, exposed t
beta-glucuronidase; Teffs, T effector cells; Tregs, T regulatory cells. Means are reportconfirm SHS exposure in some subjects, we performed
urinary cotinine analysis on a subset of subjects from our
Fresno cohort, and found that there was a significantly
higher level of urinary cotinine in our questionnaire-
determined SHS vs. nSHS subjects.
In both cohorts, we found that subjects exposed to
SHS showed a significantly greater percentage of methy-
lation of CpG sites in the IFN-γ promoter in their T ef-
fector cells when compared to the Teffs of subjects not
exposed to SHS (Figure 2A). Consequently, expression of
IFN-γ was significantly decreased in the Teffs of SHS
subjects in comparison with the Teffs of nSHS subjects
in both cohorts (Figure 2B). Interestingly, while there
was a significant increase in methylation and decrease in
expression of IFN-γ in Teffs associated with AAP expos-
ure (that is, between the FSHS and SSHS groups and be-
tween the FnSHS and SnSHS groups), we saw no
significant difference in the levels of methylation asso-
ciated with AAP exposure alone (FnSHS) vs. SHS expos-
ure alone (SSHS), though we did see a significant
difference between expression levels of IFN-γ in both
groups, with decreased expression in Teffs from FnSHS
subjects vs. Teffs from SSHS subjects. When we per-
formed linear regression analysis to determine the associ-
ation between frequency of methylation and expression
levels of IFN-γ, our results were inconsistent within the
individual groups (FSHS, FnSHS, SSHS, SnSHS; data not
shown), but we found a significant negative association
between methylation and expression of IFN-γ in Teffs in
both the SHS and the nSHS groups (Figures 2C,D) that
was also seen when data from all subject sizes were ana-
lyzed (Figure 2E), with increases in R2 values also seen as
population size increased. The disparity at the smallerd of Foxp3 in T regulatory cells for all subjects
S Fresno nSHS Stanford SHS Stanford nSHS
(n = 31) (n =6) (n = 34)
12% 41.29%± 1.94% 46.67%± 2.47% 24.85%± 5.80%
05 1.52 ± 0.11 2.25 ± 0.17 3.53 ± 0.07
24% 54.44%± 2.83% 62.0%± 1.80% 18.41%± 0.09%
05 3.29 ± 0.35 4.8 ± 0.09 7.2 ± 0.08
o secondhand smoke; nSHS, not exposed to secondhand smoke; GUS,
ed ± SEM.
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sample size rather than to any true difference between
populations, as increasing the sample size led to more
consistent and significant data. We can therefore con-
clude that there is in fact a negative association between
CpG methylation of the IFN-γ promoter regions and ex-
pression of IFN-γ in Teffs, a result that matches those of
previous studies [20-22]. Furthermore, as IFN-γ is the
major Th1 cytokine [24], our finding of increased methy-
lation and decreased expression of IFN-γ in Teffs of sub-
jects exposed to SHS and subjects exposed to AAP, as
well as subjects exposed to both, suggests that SHS and
AAP impair normal Th1 function both independently
and in conjunction with each other. However, as we did
not assess Teff or Th1 function, we cannot verify this.
Similarly, we found that subjects exposed to SHS had a
significantly greater percentage of methylation of CpG
sites in the promoter and intron regions of Foxp3 in their
regulatory T cells when compared to Foxp3 in the Tregs of
nSHS subjects, and that expression of Foxp3 in the Tregs
of SHS subjects was therefore significantly decreased. The
same was true of subjects exposed to AAP vs. subjects not
exposed to AAP (Figure 4A,B). Linear regression analysis
showed a significant negative association between methy-
lation of the regulatory regions of Foxp3 and expression
of the gene within both the SHS population (Figure 4C)
and the nSHS population (Figure 4D), as well as within
the entire population (Figure 4E), despite inconsistent
associations in the individual groups; as with IFN-γ, these
inconsistencies were likely due to decreased sample size
having decreased statistical power. Stable expression of
Foxp3 is necessary for normal Treg function [25]; our
results therefore suggest that exposure to SHS or AAP
alone, and to both SHS and AAP, may impair Treg func-
tion via methylation and consequent decreased expres-
sion of Foxp3. While we did not assess Treg function, a
previous study has shown that increased methylation of
Foxp3 leads to decreased Treg activity, supporting this
conclusion [4]. The significantly increased IgE concentra-
tions in SHS subjects vs. nSHS subjects also provide posi-
tive evidence for decreased Treg function, as decreased
Treg function leads to reduced immunosuppression of
Th2 cells, leading to increased levels of the Th2 cytokines
IL-4 and IL-13, which induce increased B cell production
of IgE [36]. However, as this association was only seen in
FSHS subjects vs. nSHS subjects, it would appear that
changes in IgE are more influenced by the combination
of AAP and SHS exposure rather than AAP or SHS
alone.
As expected, we found that both AAP alone and SHS
alone were associated with significant increases in
methylation and decreases in expression of both IFN-γ in
Teffs and Foxp3 in Tregs (Figures 2A,B, 4A,B). Of greater
interest is the interaction between these exposures andtheir combined and relative effects upon the methylation
and expression of these two genes. Our finding that there
is no significant difference between the levels of methyla-
tion of IFN-γ in Teffs and the levels of methylation and
expression of Foxp3 in Tregs in subjects exposed to SHS
alone vs. subjects exposed to AAP alone suggests that
neither is more significantly associated with methylation
than the other. However, when looking at calculated ef-
fect sizes, SHS exposure alone seems to have a greater
association with methylation and transcription of both
genes than AAP exposure alone; in every measurement
except that of IFN-γ expression levels, the SHS effect size
is at least twice as large as that of the AAP effect size. (It
should, however, be noted that because our SHS-only
sample size is very small, any conclusions we draw are
more indicative of trends.) Additionally, when looking at
relative contributions of SHS and AAP to variance of the
means via two-way ANOVA, while significant effects on
the total variance were associated with both exposures,
the degree of the effect differed, with SHS contributing
more to variation of methylation of both genes and AAP
contributing more to variation of expression of both
genes. The implications of these findings are as yet un-
clear and require more data regarding timing and relative
degree of AAP and SHS exposures in relation to each
other.
Beyond their individual effects, AAP and SHS also
appear to have a greater association with altered methyla-
tion and expression of Foxp3 and IFN-γ in Tregs and
Teffs when combined, as can be seen by the increased
methylation and decreased expression of these genes in
the FSHS subjects (AAP+SHS) vs. the FnSHS subjects
(AAP alone) and the SSHS subjects (SHS alone), as well
as the increased effect size when compared with the
SnSHS group. Given that AAP and SHS both share certain
components (including PAH, which we know to be asso-
ciated with increased methylation and decreased expres-
sion of Foxp3 in Tregs [4,37]), this finding seems logical.
The details of this interaction, however, are unclear.
Looking at effect sizes for AAP and SHS on methylation
and expression of IFN-γ suggests these the two exposures
are associated with these changes in an additive fashion,
as the sum of the individual effect sizes of AAP and SHS
exposures alone is close to the effect size of AAP+ SHS
for both IFN-γ methylation and transcription. However,
two-way ANOVA found significant interaction between
AAP and SHS on variation of mean transcription levels
of IFN-γ, which would suggest a synergic association.
Foxp3 effect sizes also suggest a synergic association
rather than a perfectly additive one, but do not present a
clear picture: the effect size of AAP+ SHS is nearly twice
as large as the sum of the individual effect sizes of AAP
and SHS on Foxp3 transcription, while the effect size of
AAP+ SHS on Foxp3 methylation is nearly half the sum
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ally, while two-way ANOVA showed a significant inter-
action between AAP and SHS on the variance of Foxp3
methylation levels, suggesting a synergic association, the
interaction between the two exposures was not found to
be significant with relation to Foxp3 transcription, which
would suggest an additive association.
In part, our findings conflict with previous findings
that acute SHS exposure contributes more significantly
to clinical symptoms of asthma than does AAP exposure
[10], though it should be noted that in the Rabinovitch
et al. study, there was some overlap between measures,
as the study looked at PM2.5 as the measure of AAP,
which can also be found in SHS. However, our study
only assessed if subjects had been exposed to SHS or
not, without looking at the time of most recent exposure,
so a direct comparison between our study and the Rabi-
novitch et al. study is not appropriate (indeed, our coti-
nine assay results would suggest that a number of our
SHS subjects had not experienced acute SHS exposure in
relation to sample collection time). Additionally, we have
not yet looked at any functional assays or clinical assess-
ments to determine if the differences in methylation and
expression of our two genes of interest are borne out in
the immunophenotypes of the subjects. At the same
time, our findings are intriguing, showing that the com-
bination of AAP and SHS is more significantly associated
with methylation and expression of IFN-γ in Teffs and
Foxp3 in Tregs than independent exposure to these com-
pounds, and thus impairs normal immunosuppressive
functions to a greater degree than would be seen with
either AAP or SHS alone.
Our findings, to our knowledge, are novel in that they
show a significant relationship between SHS and AAP
and hypermethylation and therefore decreased expression
of IFN-γ and Foxp3, two genes crucial to the suppression
of the asthmatic and allergic responses. SHS exposure is
associated with increased comorbidity of asthma and al-
lergic rhinitis, but the mechanisms by which these occur
are still unclear. Several studies have implicated SHS and
AAP in epigenetic changes to the human genome, but the
list of specific genes impacted is incomplete [11,13,16,17].
We chose to study IFN-γ and Foxp3 both because of their
significance to immunosuppression and because previous
studies have associated exposure to ambient air pollution
and/or allergens with hypermethylation of these genes
[4,23,28,38]. The results of our study therefore imply that
at least one way in which SHS and AAP may contribute to
asthma and allergies is via epigenetic modifications that
disrupt the normal function of genes crucial to Teffs and
Tregs.
Our findings are supported by evidence that exposure
to cigarette smoke or AAP is associated with decreased
numbers and function of Teffs and Tregs [4,39-43].Decreased presence and activity of Teffs and Tregs have
also been implicated in the prevalence and severity of
asthma, with various studies finding skewing of Th2/Th1
ratios in favor of Th2 activity and of Th17/Treg ratios in
favor of Th17 activity in patients with moderate to severe
asthma [44-47]. We can thus infer that increased expos-
ure to SHS and AAP leads to hypermethylation of IFN-γ
in Teffs and Foxp3 in Tregs, leading to decreased expres-
sion of these genes, causing impaired function of Teffs
and Tregs that therefore leads to increased severity and
prevalence of asthma and allergies. This is supported by
our finding of elevated levels of IgE in FSHS-exposed
subjects vs. FnSHS subjects. However, since this differ-
ence between IgE levels in SHS and nSHS subjects was
not seen in the Stanford cohort, IgE and the allergic re-
sponse appears to be more associated with AAP exposure
than with SHS exposure (two-way ANOVA, however,
showed a significant SHS effect of 6.57% (P < 0.05) vs. a
significant AAP effect of 3.53% (P < 0.05)).
Our data do not provide significant evidence that SHS
or AAP and impaired Teff and Treg function are neces-
sarily causative in the development of asthma or allergic
rhinitis. Complete clinical data is needed to examine the
link between SHS and AAP and these diseases.
In addition to examining the independent associations
of AAP and SHS with the methylation and expression of
our candidate genes, we looked to see if we could begin
to determine the relative impacts of the two exposures
on mechanisms of the immune system. A previous study
conducted on patients from Denver looked at the rela-
tive impact of the two exposures on clinical symptoms,
and demonstrated that recent SHS exposure decreased
the impact of AAP on asthmatic exacerbations while
simultaneously increasing asthmatic exacerbations [10].
Similarly, we found that subjects exposed to SHS in
addition to AAP had increased methylation and decreased
expression of Foxp3 in their Tregs and of IFN-γ in their
Teffs when compared with the Tregs and Teffs of subjects
exposed to AAP alone, suggesting that SHS is associated
with aggravation of the effects of exposure to AAP.
At the same time, we did not find a significant differ-
ence in IFN-γ methylation in Teffs or in Foxp3 methyla-
tion and expression in Tregs between subjects exposed
to AAP alone and subjects exposed to SHS alone, sug-
gesting that the SHS+AAP association is a combinatory
one. Further study is needed to examine functional con-
sequences of the epigenetic modifications of IFN-γ and
Foxp3 on Teffs and Tregs, respectively, as well as to see
if these relative associations hold true for other genes.
SHS and AAP are not the only factors known to influ-
ence asthma, nor are IFN-γ and Foxp3 the only genes
relevant to the development and exacerbation of the dis-
ease [2,13,48-50]; other factors, both environmental and
genetic, are currently under investigation. We have, to
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such as pollen, dust mites, endotoxin, and mold, but
found the greatest differences associated with SHS ex-
posure or lack thereof. Going forward, we will continue
to assess these other exposures.
Moreover, SHS and AAP are not the only factors po-
tentially impacting DNA methylation. Previous studies
have demonstrated that certain genes are either hyper-
or hypomethylated with age [51-54], but no study to
date of which we know has assessed DNA modification
of Foxp3 or IFN-γ with respect to age in different T cell
subsets. When we performed linear regression of age vs.
methylation for both genes, we found no association.
Gender has also been implicated in differences in methy-
lation [15,54,55], but we found no significant difference
in methylation of either gene in any group associated
with gender, and when controlling for gender, obtained
no difference in our findings. These results suggest that
any contributions of age and gender to the methylation
of Foxp3 and IFN-γ in Tregs and Teffs, respectively, are
relatively small in relation to the impacts of SHS and/or
AAP. Future studies should, however, continue to moni-
tor age and gender.
One further confounding factor is suggested by the sig-
nificantly increased total IgE seen in FSHS patients vs.
nSHS patients. Increased IgE levels are frequently asso-
ciated with increased allergic severity [56], which is in
turn often associated with increased methylation and
decreased expression of Foxp3 in Tregs and of IFN-γ in
Teffs [21,25]. Additionally, studies have found an associ-
ation between SHS exposure and increased IgE levels
[57]. This suggests that SHS might affect methylation by
increasing allergic severity. Overall allergic severity for a
given subject, however, is difficult to determine [58,59];
we did perform skin tests and administer questionnaires
concerning allergic rhinitis, and found that subjects with
a total IgE >25 kU/L reported symptoms of allergic rhin-
itis. Given our small sample size, however, we can only
infer at this point that total IgE levels may be indicative
of clinical atopy. Additionally, given the measures we
examined, we did not see any significant difference in
allergic severity between SHS and nSHS subjects; the
most significant difference between the populations was
their SHS exposure status, suggesting that SHS influ-
ences methylation directly rather than via an intermedi-
ate. It should also be noted that, while increased total IgE
is frequently correlated with increased allergic severity,
this does not always hold true [60].
Further limitations of our study include our small
sample size, as well as the lack of temporality, given that
this is a cross-sectional analysis.
Future studies should aim to correlate our findings of
genetic differences with phenotypic differences. Teff and
Treg functional assays should be performed to determineif the observed changes in methylation and expression of
IFN-γ and Foxp3, respectively, impair the normal behavior
of these cells. Immunophenotype analysis to evaluate the
relative numbers and activity levels of Teffs and Tregs
between SHS and nSHS subjects (with and without AAP)
from this study should also be performed. Moreover, data
from more subjects should be added to our analysis to
increase the potential significance of our findings, and
data should be collected at multiple time points to exam-
ine the temporality of these methylation associations, if
any exist. Along these lines, it will also be important to
gain a more nuanced picture of the association between
these exposures and methylation of these genes, looking
at such factors as timing of exposure, duration and extent
of exposure, prenatal vs. postnatal exposure (particularly
with respect to SHS), and whether this methylation asso-
ciation persists after the exposure has been removed
from the environment. Additionally, clinical allergy and
asthma profiles and their potential relation to SHS expos-
ure, both with and without AAP, should be examined. To
better understand the mechanisms underlying expression
of both IFN-γ and Foxp3, methylation at individual CpG
sites should also be analyzed. Finally, it is necessary to
study other genes important in allergies and asthma that
could be epigenetically modified, with repeated measure-
ments performed for these genes as well as IFN-γ and
Foxp3 to assess the durability of these changes over time.
Conclusions
We show that there are significant epigenetic differences
in two key genes known to be associated with immuno-
logical changes in allergy and asthma between groups of
children exposed to SHS (both in combination with
AAP and not) and a group of controls. Our data demon-
strate a significant association between SHS and AAP
and hypermethylation and decreased transcription of
IFN-γ and Foxp3 in T effector and T regulatory cells, re-
spectively, in comparison with SHS exposure alone and
AAP exposure alone. This suggests a possible mechan-
ism by which SHS and AAP may be associated with the
development and progression of asthma and allergies, as
decreased levels of expression of these genes have been
linked with increased prevalence and severity of asthma
and allergic disease [39-47]. Further studies are needed
to elucidate the precise relationship between SHS and
AAP and these epigenetic changes, as well as to correlate




Participants were recruited from the Fresno Unified
School District and screened at the Fresno Field Office
(work supported by the NIEHS/EPA P20 Children’s
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aged between 11 and 18 years, all residents of Fresno for
at least 9 years, provided informed consent and were
enrolled into this study. All of these individuals were
selected for detailed study regarding the changes in
methylation of IFN-γ and Foxp3 associated with SHS. In
addition, we recruited a control group (Stanford cohort)
which consisted of 40 subjects from Palo Alto, California,
a region with relatively low ambient air pollution
(California Air Resources Board (CARB), www.arb.ca.
gov). All control subjects had lived in Palo Alto for at
least 6 years and lived at least 800 m from any major
highways. All study components were approved by the
Institutional Review Board (IRB) of Stanford University.
Urine and blood samples were collected on all partici-
pants. Blood and urine were stored according to pub-
lished procedures. In short, urine was initially stored at
−20°C before being transferred to a −80°C freezer. Per-
ipheral blood mononuclear cells (PBMCs) were extracted
from blood via the ficoll procedure, slowly frozen to
−80°C overnight, and then stored in liquid nitrogen.
Plasma was extracted from the blood at the same time
and stored at −80°C. Plasma IgE levels for subjects at the
time of blood draw were determined. PBMCs were fur-
ther purified for CD4+CD25neg Teff cells and, separately,
for CD4+CD25hi Treg cells (FACS Aria, BD Biosciences).
IFN-γ and Foxp3 methylation data were obtained for all
enrolled subjects.
Measures of exposure to AAP
AAP was measured and individual estimate exposures
were determined for all Fresno subjects. All subjects were
monitored for PM2.5, PM10, PAH, and ozone through
methods reported previously [4], using data from CARB.
Briefly, daily pollutant exposures were assigned to sub-
jects on the basis of measurements from the nearest
CARB monitoring site (Fresno subjects: First Street,
Fresno, CA; Stanford subjects: Redwood City, CA), using
the following measures: 8-h daily maximum ozone (O3)
concentration; and 24-h average concentrations of PM2.5,
PM10, and PAH. For Fresno subjects, daily First Street
data were used directly for all pollutants except PAHs.
Each subject’s individual PAH exposure estimate for a
cumulative 12 months of exposure (the 12 months prior
to the clinic visit in which the questionnaire for SHS was
administered) was calculated based on land use regres-
sion analyses, which formalize the relationship between
measurement site and local environmental variables such
as traffic flow and land cover and allow for consideration
of temporal and spatial variation [61,62], using measure-
ments taken at subjects’ homes. AAP exposure analysis
was performed by collaborators from UC Berkeley and
the Fresno field office. Because this was cumulative over
12 months, seasonal effects were not taken into account.These data and a more detailed description of these
methods can be found in our previously published
paper [4].
Measures of exposure to SHS
All subjects were monitored for secondhand smoke
exposure via questionnaires asking the parents: ‘Do you
currently smoke?’ and ‘Does anyone who currently
spends time with the child smoke?’ On the basis of the
responses to these questionnaires, 62 subjects from the
Fresno cohort, 31 exposed to SHS and 31 not, were
chosen for IFN-γ and Foxp3 methylation study. To con-
firm the accuracy of our questionnaire in determining
SHS exposure, an enzyme-linked immunosorbent assay
(ELISA) for measures of cotinine in the urine was per-
formed as a proof of concept in a small subset of FSHS
(n = 16) and FnSHS (n = 6) patients using a modified
High Sensitivity Cotinine EIA assay (Salimetrics, State
College, PA, USA) with a limit of detection of 0.1 ng/mL.
Based on Thompson et al. [63], a cutoff of 7 ng/mL was
considered positive for very recent exposure to SHS.
Purification of T cells
CD4+ T cells were enriched by incubation with the nega-
tive selection CD4+ isolation kit from Stem Cell Tech-
nologies (Vancouver, BC, Canada). We centrifuged 1:1
heparinized whole blood phosphate-buffered saline (PBS)
with 1% BSA at 450 g for 40 minutes over Ficoll-Hypaque
density gradients. The CD4+ T-cell-containing PBMC
layer was collected and washed twice with 10 mL PBS at
4°C. After centrifugation at 250 g for 15 minutes, cells
were resuspended in PBS in flow cytometry staining
tubes. Live/Dead staining (Molecular Probes/Invitrogen,
Grand Island, NY, USA) was used in all samples. Live
cells were identified by the intracellular conversion of a
calcein ester to free calcein (intensely fluorescent in the
green spectrum), and dead cells were identified by the
red staining of internal nucleic acids by ethidium homo-
dimer. Subsequently, the live cell fraction was stained
with CD4-fluorescein isothiocyanate (clone SK3; BD
Biosciences, San Jose, CA, USA), CD25-phycoerythrin
(clone 4E3; Miltenyi Biotec, Auburn, CA, USA) and
CD127 (IL-7 receptor α-chain) allophycocyanin (clone
SB199; BioLegend, San Diego, CA, USA) antibodies and
sorted by flow cytometry for live CD4+CD25hiCD127lo/-
Treg cells (FACS Aria; BD Biosciences, San Jose, CA).
CD127 depletion occurred to ensure separation of acti-
vated conventional T cells from stable Treg-cell popula-
tions, which allowed for the isolation of highly enriched
Foxp3+ cells. Live non-Treg (CD4+CD25-) cells (subse-
quently called conventional effector CD4+ T cells or Teffs)
were flow-sorted simultaneously. Past experiments with
multicolor flow-cytometry staining for CD4+CD25hiCD127lo
(Treg) cells and CD4+CD25- (Teff) cells have demonstrated
Table 4 Oligonucleotides used for bisulphite-specific polymerase chain reaction and pyrosequencing of IFN-γ










+122~ Forward 5′-[Biotin] TTTTGGATTTGATTAGTTTGATATAAGAA-3′
+128 Reverse 5′-AAAACCCAAAACCATACAAAACTAAAA-3′
Sequencer 5′-CTAAAAAACCAAAATATAACTTAT-3′
+171 Forward 5′-[Biotin] TTTTGGATTTGATTAGTTTGATATAAGAA-3′
Reverse 5′-CATTTTCAACCACAAACAAATACTATTAA-3′
Sequencer 5′-ACAACCAAAAAAACCC-3′
*CpG sites indicate nucleotide position in relation to transcription start. Symbols – and+ indicate upstream and downstream of transcription start, respectively.
CpG, cytosine nucleotide neighboring guanine.
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Treg and Teff cells were incubated in RPMI-1640 media,
10% fetal bovine serum (FBS), and 1% L-glutamine after
purification for 2 h before undergoing further experiments.
All experiments were controlled for live cell number.
DNA isolation and sodium bisulphite conversion
Genomic DNA was isolated from purified Teff and, sep-
arately, Treg cells, from each subject’s samples using a
DNeasy Mini Kit (Qiagen, Valencia, CA, USA) according
to the manufacturer’s instructions and controlling for
cell number. Genomic DNA was bisulphite-treated using
published procedures [4]. Briefly, 1 to 2 μg of genomic
DNA in 45μL of nuclease-free water was denatured at
42°C for 20 minutes with 5μL of freshly prepared 3 M
sodium hydroxide. Denatured DNA was incubated with
freshly prepared sodium bisulphite (saturated) and hydro-
quinone solution in the water bath at 55°C for 16 h. The





Description 6 CpG sites*
(-141, -95, -80, -66, -54, -27)
*CpG sites indicate nucleotide position in relation to transcription start. Symbols – a
CpG, cytosine nucleotide neighboring guanine.DNA Clean-up Column (Promega, Madison, WI, USA)
and then desulphonated by incubation with 5.5μL of a
3 M NaOH solution at 37°C for 20 minutes. The
bisulphate-treated DNA was finally precipitated with etha-
nol, and then redissolved in 25 μL of 1 mM Tris-Cl pH 8.
IFN-γ bisulphite-specific polymerase chain reaction (PCR)
and pyrosequencing
The detailed information of primers used in the bisulphite-
specific PCR can be found in Table 4. For methylation
analysis, five amplicons, amplified using a HotStar
Taq kit (Qiagen, Valencia, CA, USA), included a total
of six CpG sites within the proximal promoter region
of IFN-γ (Figure 1). Direct quantification of methylated
vs. unmethylated cytosine nucleotides for each analyzed
CpG site present in the amplicons was determined by pyr-
osequencing with the PSQ HS 96 Pyrosequencing System
(Qiagen) and Pyro Gold CDT Reagents (Qiagen) as





(+3951, +3956, +4105, +4224, +4228, +4236, +4245)
nd+ indicate upstream and downstream of transcription start, respectively.
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more. In each pyrosequencing assay, one amplicon was
used for sequencing; the corresponding sequencer can be
found in Table 4. Internal controls for bisulphite conver-
sion efficiency were included in each pyrosequencing
assay. A genomic sequence that is artificially methylated
on all its CpG dinucleotides (catalogue number S7821,
Millipore, Billerica, MA, USA) was also used in the bisul-
phite conversion, PCR, and pyrosequencing with the pri-
mers and sequencers mentioned above as a technical
control.
Foxp3 bisulphite-specific PCR and pyrosequencing
Identification of Foxp3 CpG loci of interest (Figure 3)
was based on our previous studies [4] of two regions
where we found increased methylation of the 8 CpG
islands in the promoter region and of the 13 CpG
islands in the intronic regions. Demethylation of these
two regions was associated with stable Foxp3 expression
in memory Tregs. Partial methylation was associated
with unstable Foxp3 expression in Tregs. In contrast, the
promoter and intronic regions of Foxp3 in conventional
CD4+ T cells are methylated. Table 5 gives detailed infor-
mation about the primers used in the bisulphite-specific
PCR.
To display the methylation data for both genes, we
first obtained pyrosequencing data as to whether a par-
ticular CpG site was methylated (a threshold of 70% or
higher methylation frequency was considered a methy-
lated CpG site) in purified T cells that were controlled
for cell number. Then, to calculate a separate percentage
of CpG sites for a given locus, we divided the total num-
ber of methylated CpG sites (numerator) for a specific
genetic locus (either Foxp3 or IFN-γ) by the total CpG
sites sequenced (denominator) and used this percentage
in our figures presented here.
CpG islands were determined using NCBI gene searches,
BLAST for sequence information; primers were determined
using PyroMark Assay Design Software (Qiagen).
Quantitative real-time PCR
Total RNA was isolated from purified cells with the use of
an RNeasy Mini Kit (Qiagen). cDNA from 500 ng of total
RNA was synthesized using an Omni script Kit (Qiagen)
and random declaimer primers (catalogue number 5722E,
Austin, TX, USA). Real-time PCR was performed with
1μL of synthesized cDNA, 12.5μL TaqMan Universal PCR
mix, and 1.25μL 20X assay on demand gene expression
assay mix (Mm00445273_m1, Applied Biosystems, Foster
City, CA, USA), in a 7000 Sequence Detection System
(ABI Prism, Applied Biosystems, Carlsbad, CA, USA).
Each sample was performed in duplicate. The ribosomal
18S Control Reagents (part number 4308329), also from
Applied Biosystems, was used as an endogenous controlfor data normalization. The relative quantity of IFN-γ and
Foxp3 mRNA was calculated against GUS values accord-
ing to the methods published by our group [4].
Statistical analysis
Two-way ANOVA was performed to compare the rela-
tive associations of AAP and SHS with methylation and
expression, and followed by t-tests to compare the
means of all parameters tested. Effect sizes were calcu-
lated using Hedge’s g and reported with the 95% confi-
dence interval. Linear regression analysis was applied to
determine the association between percent CpG methy-
lation (averaged across all CpG sites examined for each
gene) and expression levels for IFN-γ and Foxp3 in Teffs
and Tregs, respectively. Linear regression analyses were
also performed to determine if any confounding associ-
ation existed between the demographic factors of age
and gender. The threshold for all statistical significance
was set at P < 0.05. All statistical analysis was performed
with the Graph Pad Prism Software (Prism Software, La
Jolla, CA, USA).Competing interests
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